Are you implying Phoenix Group is only worth $4 million? I would not put your money on TCRI being used as the merger shell company for Phoenix. JMO. Is Charlie still involved here? Since this company has no news or growth, I would guess yes. Good luck while that moron is still CEO.
What is your thoughts on using this shell to go public with Phoenix Group. Personally I am trying to weigh the pros and cons. I think a SPAC is out the question. Therefore, would a direct listing be better or a reverse merger? I know they would have to dilute at least 40 million worth of shares with the shell but they wouldn’t have to jump on the Nasdaq and only sell the shares they currently own. Which would allow for more growth and control which they seem to feel very confident and committed that they will grow a lot in the next 5 years. And a firm commitment of 40 million worth of shares wouldn’t even be that much dilution. Not to mention that with timing seeming to be of importance here then a reverse merger would be much easier to manage rather than a traditional IPO. What do you think? I know it’s all speculation but understanding the dynamics at play, what makes more sense here knowing that they are now announcing a commitment to get on the Nasdaq and the changes this past week. Plus the shell seems to be very clean and well managed. After writing that I probably have an idea considering you position but hearing your thoughts would be nice.
I don't have much knowledge of all the details and factors involved in dual listings. For example, I don't know to what extent (if any) that Phoenix's current listing over in the UAE has any influence on exactly how it wants or needs to approach/structure its listing here in the United States. So there are probably people out there who would have more valuable opinions on this. I would imagine that Phoenix is getting quite a bit of advice/feedback from the financial institutions it is working with on its plans for a Nasdaq listing. And I think it is probably more likely than not that those institutions would be more interested in steering Phoenix in the direction of a more normal/traditional IPO listing.
I'm not ruling out the possibility of Phoenix deciding to use the TCRI shell for a Nasdaq listing. Phoenix definitely was interested in going public via the reverse merger route with TCRI back around that 2021-2022 time period so this is a possibility that can't be completely dismissed. Had the market conditions and crypto regulatory environment in the United States been more favorable at that time, Phoenix might have proceeded with its original plan and we would not be having this discussion today.
There are some aspects to doing a reverse merger with TCRI and subsequent uplisting that could be extremely enticing to Phoenix from an overall financial/control standpoint. I have little doubt that Phoenix would be able to attract a $40M financing from institutions if it wanted to bypass that mandatory one-year waiting period for reverse merger companies looking to uplist. Assuming that Phoenix has the pull to get whatever FINRA actions (name/symbol/split) it needed processed in a timely manner (which can be a lengthy nightmare for many OTC stocks) then this route to a Nasdaq listing would be reasonably easy for them. It probably would be the single best way for Phoenix to maximize the value of its TCRI investment.
Having said that, I can also see where Phoenix may view TCRI as being better-suited as a vehicle for another part of its business/growth strategy. That could include continuing to pursue whatever plan they were developing with Charlie/Simon, or maybe using TCRI to bring public another company that Phoenix may have identified through its business relationships/investments.
Maybe here in the first half of 2025 we might get some indication of what direction Phoenix and TCRI will take. Over the next 4 months we should be getting 2 periodic reports from TCRI and 2 earnings conference calls from Phoenix.